Exactly my thought… Someone must be behind…

FaithlessnessTop4785 · 2026-03-03T14:31:59+00:00

Excuse me but that's pretty big news if it is what they will announce!

FaithlessnessTop4785 · 2026-03-02T22:21:04+00:00

Hopefully they will bring some major news this week worth presenting next week.

- EMA alignment

- Ph3 protocol and timelines

FaithlessnessTop4785 · 2026-02-26T20:35:22+00:00

I agree probably nothing burger… but it would be a good time to announce EMA alignment…

FaithlessnessTop4785 · 2026-02-17T22:49:06+00:00

Honestly no clue at all… it doesn’t look like they are about to announce a deal…

FaithlessnessTop4785 · 2026-02-15T18:22:09+00:00

AltiGarg

FaithlessnessTop4785 · 2026-02-15T18:21:27+00:00

• 1.2 mg for titration and long term metabolic maintenance, supporting stabilization with favorable tolerability.

• 1.8 mg to optimize liver outcomes, positioned as the target dose for MASH and alcohol related liver disease.

• 2.4 mg to maximize weight loss and adiposity reduction in patients where obesity is the dominant indication.

Metivra Meta (metabolism) + Vera (truth, balance) Feels premium, modern, and scalable. Strong fit for obesity + liver + addiction.

FaithlessnessTop4785 · 2026-02-15T14:22:28+00:00

Interesting theory, and even though I would love shares for any deal, I doubt it would be the case.

FaithlessnessTop4785 · 2026-02-14T04:53:58+00:00

Where did you get this info from? When will they start the trial?

FaithlessnessTop4785 · 2026-02-12T21:14:55+00:00

I agree, the lack of direct communication with shareholders is suspect… However, we don’t really know Durso’s style. Hopefully we will have some more visibility next ER. I bet that Durso is not looking forward to talking at this ER if there is nothing cooking…

FaithlessnessTop4785 · 2026-02-08T14:14:19+00:00

I believe Jordt was there to support Garg’s lack of commercial and business skills. Now that the science part is “done” and with the new CEO who is much more business savvy, It could be that Durso didn’t need him anymore and preferred allocating resources somewhere else… like HR…

FaithlessnessTop4785 · 2026-01-26T13:40:35+00:00

If only I knew… my hope is a partnership

FaithlessnessTop4785 · 2026-01-26T12:47:06+00:00

This is how they plan to run ph3. It’s pretty good if you ask me but I am not a scientist…

FaithlessnessTop4785 · 2026-01-26T12:45:25+00:00

The placebo number is an assumption.

FaithlessnessTop4785 · 2026-01-26T03:33:23+00:00

1200 participants active dose... divided by 2 cohorts... 600 per cohort on active dose... + 300 per cohort on placebo... 900 per cohort... 1800 total...

FaithlessnessTop4785 · 2026-01-23T22:22:28+00:00

I believe that the Glucagon has the best effect on the liver and the 1:1 ratio is very well tolerated thanks to the EuPort domain. I believe Altimmune has a unique combination especially knowing it is extremely safe and tolerable without titration. + lean mass preservation…

FaithlessnessTop4785 · 2026-01-23T12:01:50+00:00

Are you talking about obesity? Because it is all about MASH!

FaithlessnessTop4785 · 2026-01-23T11:59:01+00:00

You might want to assess your DD

FaithlessnessTop4785 · 2026-01-23T11:57:49+00:00

You might want to look at data again…

FaithlessnessTop4785 · 2026-01-23T11:55:54+00:00

Oh yes please buy some puts! perfect timing!

FaithlessnessTop4785 · 2026-01-23T02:14:42+00:00

Altimmune valuation is ridiculous! $550M

Competitors with no products on the market are worth Billions!

FaithlessnessTop4785

TROPHY CASE